epigallocatechin gallate has been researched along with Bladder Cancer in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Arjunan, A; Jeong, JU; Jung, YD; Khoi, PN; Li, S; Sah, DK | 1 |
| Chang, WA; Chen, YJ; Ke, HL; Kuo, PL; Lee, HY; Li, WM; Wu, WJ | 1 |
| Cai, J; Kang, L; Li, J; Li, Y; Liu, X; Luo, J; Yin, Z; Zhang, L | 1 |
| Bednarski, W; Dettlaff, K; Jankun, J; Jelińska, A; Keck, RW; Khan, OA; Mostafa, IH; Ogrodowczyk, M; Stawny, M; Wątróbska-Świetlikowska, D | 1 |
| Geng, H; Li, E; Li, Y; Song, J; Sun, X; Yu, D; Zhong, C | 1 |
| Jankun, J; Keck, RW; Selman, SH | 1 |
| Lei, T; Wang, S; Zhang, M | 1 |
| Cai, ZM; Cheng, BH; Huang, WR; Lung, WY; Luo, KW; Wei, XY | 1 |
| Keck, RW; Selman, SH | 1 |
| Chen, NG; Chung, JG; Ho, YJ; Lai, CH; Lin, TH; Lin, YC; Lin, YH; Lu, CC; Shen, WC; Yang, JS | 1 |
| Hsieh, DS; Huang, YH; Tan, SW; Tsai, CY; Wang, H; Wu, CJ; Yeh, MK | 1 |
| Chen, SC; Chiang, CK; Chuang, YT; Huang, KH; Kuo, KL; Liu, SH; Pu, YS; Tsai, YC; Weng, TI | 1 |
| Bai, Y; Kong, D; Lin, Y; Mao, Q; Qin, J; Wang, Y; Xie, L; Yang, K; Zheng, X | 1 |
| Gomez, MA; Hampton, JA; Keck, RW; Kemberling, JK; Selman, SH | 1 |
| Facchini, A; Flamigni, F; Guarnieri, C; Stefanelli, C; Zanella, B | 1 |
| Chen, JJ; Koo, MW; Ye, ZQ | 1 |
| Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF | 1 |
| Bai, Y; Dahiya, R; Li, LC; Qin, J; Shen, HF; Wang, YB; Xie, LP; Zheng, XY | 1 |
| Bernier, T; Hanley, R; Kim, J; Le, SM; Libertino, JA; Lodowsky, C; Marie, PJ; Rieger-Christ, KM; Roth, M; Summerhayes, IC; Vemulapalli, P; Yee, AS | 1 |
19 other study(ies) available for epigallocatechin gallate and Bladder Cancer
| Article | Year |
|---|---|
(-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells.
Topics: Humans; NF-kappa B; Receptors, Urokinase Plasminogen Activator; Transcription Factor AP-1; Urinary Bladder Neoplasms | 2022 |
Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma-Next-Generation Sequencing and Bioinformatics Approaches.
Topics: Anticarcinogenic Agents; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Computational Biology; High-Throughput Nucleotide Sequencing; Humans; MicroRNAs; Signal Transduction; Urinary Bladder Neoplasms | 2019 |
Epigallocatechin-3-gallate induces autophagy-related apoptosis associated with LC3B II and Beclin expression of bladder cancer cells.
Topics: Apoptosis; Autophagy; Beclin-1; Catechin; Cell Line, Tumor; Humans; Microtubule-Associated Proteins; Phosphatidylinositol 3-Kinases; Urinary Bladder Neoplasms | 2021 |
Formulation and characterization of EGCG for the treatment of superficial bladder cancer.
Topics: Anticarcinogenic Agents; Catechin; Chromatography, High Pressure Liquid; Cold Temperature; Filtration; Freeze Drying; Humans; Radiation, Ionizing; Sterilization; Urinary Bladder Neoplasms | 2017 |
(‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
Topics: Biomarkers, Tumor; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Neoplastic Stem Cells; Signal Transduction; Urinary Bladder Neoplasms | 2019 |
Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model.
Topics: Animals; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Mitomycin; Neoplasms, Experimental; Rats; Urinary Bladder Neoplasms | 2014 |
The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Neoplasm Proteins; Pyrazines; Urinary Bladder Neoplasms | 2016 |
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Injections, Intraperitoneal; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; NF-kappa B; Random Allocation; Specific Pathogen-Free Organisms; Tumor Burden; Urinary Bladder; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2017 |
A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model.
Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Mitomycin; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 2011 |
Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; HSP27 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proteomics; Proto-Oncogene Proteins c-akt; Random Allocation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2011 |
The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Gold; Immunologic Factors; Male; Mice; Nanoparticles; Tea; Urinary Bladder Neoplasms | 2011 |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.
Topics: Apoptosis; Catechin; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Down-Regulation; Drug Synergism; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; G1 Phase Cell Cycle Checkpoints; Heat-Shock Proteins; Humans; Indoles; Leupeptins; Pyrazoles; RNA, Small Interfering; Stress, Physiological; Sulfonamides; Unfolded Protein Response; Urinary Bladder Neoplasms | 2012 |
Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB‑mediated matrix metalloproteinase-9 expression.
Topics: Anticarcinogenic Agents; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Fibronectins; Humans; Matrix Metalloproteinase 9; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Urinary Bladder Neoplasms | 2012 |
Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Catechin; Dose-Response Relationship, Drug; Free Radical Scavengers; Rats; Rats, Inbred F344; Tea; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
Effect of green tea extract on the induction of ornithine decarboxylase and the activation of extracellular signal-regulated kinase in bladder carcinoma ECV304 cells.
Topics: Apoptosis; Caspases; Catechin; Cell Survival; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Plant Extracts; Tea; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line.
Topics: Antineoplastic Agents, Phytogenic; Camellia sinensis; Catechin; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Phytotherapy; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder Neoplasms | 2004 |
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms | 2006 |
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Urinary Bladder Neoplasms | 2007 |
The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Topics: Animals; Anticarcinogenic Agents; Cadherins; Catechin; Catenins; Cell Line, Tumor; Cell Movement; Down-Regulation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Transplantation; Signal Transduction; STAT3 Transcription Factor; Tea; Transplantation, Heterologous; Urinary Bladder Neoplasms | 2007 |